Internal Medicine · Charlestown, IN
NPI
1619963105
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
5
Hospital affiliations
9431 County Road 403
Charlestown, IN, 47111
Phone (812) 256-6391
Medicare paid, 2024
$125K
2,663 services
Medicare patients, 2024
255
Average age 72
Drug cost, 2024
$2.7M
19,945 prescriptions
Company payments, 2025
$1,898
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph H Beaven was code 99214 (office e&m - established), 1,305 times for 254 patients. In total Joseph H Beaven billed 2,663 services in 16 codes, and Medicare paid $125K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,305 | 254 | $86.50 | $113K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 707 | 206 | $11.81 | $8,347 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 360 | 23 | $0.36 | $130 |
| 96372 Injection Administration | Office | 91 | 23 | $10.54 | $959 |
| 17000 Destruction Skin Lesion | Office | 26 | 14 | $47.68 | $1,240 |
| 17003 Destruction Skin Lesion | Office | 26 | 14 | $4.70 | $122 |
By year: 2022 $129K for 2,776 services; 2023 $121K for 2,588 services; 2024 $125K for 2,663 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 115 | 61 | $3.23 | $371 |
Medicare prescription drug claims, 2024
In 2024, the drug Joseph H Beaven prescribed most often to Medicare patients was Alprazolam, with 682 prescriptions and refills. In total Joseph H Beaven wrote 19,945 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alprazolam Generic | 682 | 682 | 93 | $5,585 |
| Allopurinol Generic | 455 | 1,248 | 143 | $3,352 |
| Omeprazole Generic | 452 | 1,121 | 139 | $5,142 |
| Atorvastatin Calcium Generic | 447 | 1,163 | 133 | $2,508 |
| Gabapentin Generic | 432 | 714 | 107 | $7,023 |
| Prednisone Generic | 421 | 424 | 224 | $1,683 |
| Levothyroxine Sodium Generic | 410 | 1,074 | 121 | $4,656 |
| Metoprolol Tartrate Generic | 409 | 1,092 | 134 | $1,794 |
| Pantoprazole Sodium Generic | 404 | 1,122 | 133 | $5,769 |
| Fenofibrate Generic | 376 | 1,028 | 134 | $5,611 |
| Montelukast Sodium Generic | 369 | 1,008 | 110 | $2,490 |
| Farxiga Dapagliflozin Propanediol | 318 | 492 | 76 | $273K |
| Amlodipine Besylate Generic | 296 | 715 | 87 | $1,428 |
| Furosemide Generic | 294 | 731 | 101 | $1,059 |
| Hydralazine Hcl Generic | 284 | 739 | 95 | $3,751 |
Brand drugs: 3,044 claims; generic drugs: 16,762 claims; opioid claims: 381.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph H Beaven $1,898 ($1,898 in general payments such as food, travel and fees) from 24 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $638.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 23 | $638 |
| Phathom Pharmaceuticals, Inc. PHAT | 24 | $242 |
| Amgen Inc. AMGN | 10 | $190 |
| Exact Sciences Corporation EXAS | 5 | $106 |
| Abbvie Inc. ABBV | 5 | $95.81 |
| Vanda Pharmaceuticals Inc. VNDA | 4 | $84.02 |
| Axsome Therapeutics, Inc. AXSM | 4 | $71.79 |
| Lundbeck LLC | 3 | $57.03 |
| GlaxoSmithKline, LLC. GSK | 3 | $46.42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.